Tuesday, February 16, 2010

Syncom Healthcare witnesses

Indore based Syncom Healthcare, which is engaged in the business of manufacturing, marketing and distribution of pharmaceutical formulations under own brands of Ethical, OTC, Generic and Herbal market segment, closed first session with a premium of 14.4% at Rs 85.80 as against issue price of Rs 75 on Monday.

The stock has witnessed 222 bulk deals, including 151 deals on NSE and 71 on BSE. It has seen an intraday high of Rs 107.20 but profit booking at higher levels erased some gains.

Indore based Syncom Healthcare had entered capital market with public issue of 75,00,000 equity shares during January 27-29, 2010 and its issue was subscribed 5.17 times. The price band was at Rs 65-75.

The company raised Rs 56.25 crore from this issue. The proceeds from the issue will be used for setting up new manufuring unit at Indore SEZ for various pharmaceuticals formulations; undertaking the upgradation/modernization of manufacturing facilities at Dehradun Plant; working capital requirements; setting up an export office at Mumbai and undertaking Brand & Product Registration and Approval.

Source : http://www.moneycontrol.com/news/ipo-new-listings/syncom-healthcare-witnesses-222-bulk-deals_441892.html

No comments: